CRISPR-Cas Systems in Streptococci

被引:7
|
作者
Gong, Tao [1 ]
Lu, Miao [1 ]
Zhou, Xuedong [1 ]
Zhang, Anqi [1 ]
Tang, Boyu [1 ]
Chen, Jiamin [1 ]
Jing, Meiling [1 ]
Li, Yuqing [1 ]
机构
[1] Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
ADAPTIVE IMMUNITY; ANTI-CRISPR; RNA; DNA; BACTERIOPHAGE; EVOLUTION; INSIGHTS; CLASSIFICATION; GENERATION; SEQUENCES;
D O I
10.21775/cimb.032.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Streptococci are one of the most important and common constituents of the host's microbiota and can colonize and live in the upper respiratory and urogenital tract of humans and animals. The CRISPR-Cas systems (i.e., clustered regularly interspaced short palindromic repeat, with CRISPR-associated proteins) found in bacteria and archaea provide sequence-based adaptive immunity against mobile genetic elements, especially in the streptococci. Here, recent research progress on CRISPR-Cas systems in the streptococci is reviewed, including their classification (mainly type I, type II, and type III), physiological function, defense mechanism (CRISPR adaptation, crRNA biogenesis, and target interference) and applications, which are useful for a better understanding of the functions of such systems. Finally, the advances that have been made in streptococci may help in the discovery of further novel CRISPR-Cas systems for use in new technologies and applications in other species.
引用
收藏
页码:1 / 37
页数:37
相关论文
共 50 条
  • [41] CRISPR-Cas bioinformatics
    Alkhnbashi, Omer S.
    Meier, Tobias
    Mitrofanov, Alexander
    Backofen, Rolf
    Voss, Bjoern
    METHODS, 2020, 172 : 3 - 11
  • [42] Sabotage of CRISPR-Cas
    Du Toit, Andrea
    NATURE REVIEWS MICROBIOLOGY, 2024, 22 (01) : 1 - 1
  • [43] CRISPR-Cas Systems and Genome Editing: Beginning the Era of CRISPR/Cas Therapies for Humans
    Karpov, Dmitry S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (10)
  • [44] Editing and investigating genomes with TALE and CRISPR/Cas systems: Applications of artificial TALE and CRISPR-Cas systems
    Giovannangeli, Carine
    Concordet, Jean-Paul
    METHODS, 2014, 69 (02) : 119 - 120
  • [45] The basic building blocks and evolution of CRISPR-Cas systems
    Makarova, Kira S.
    Wolf, Yuri I.
    Koonin, Eugene V.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2013, 41 : 1392 - +
  • [46] Phage Genetic Engineering Using CRISPR-Cas Systems
    Hatoum-Aslan, Asma
    VIRUSES-BASEL, 2018, 10 (06):
  • [47] Microbial production of chemicals driven by CRISPR-Cas systems
    Shi, Shuobo
    Qi, Nailing
    Nielsen, Jens
    CURRENT OPINION IN BIOTECHNOLOGY, 2022, 73 : 34 - 42
  • [48] Rational designs of in vivo CRISPR-Cas delivery systems
    Xu, Cong-Fei
    Chen, Guo-Jun
    Luo, Ying-Li
    Zhang, Yue
    Zhao, Gui
    Lu, Zi-Dong
    Czarna, Anna
    Gu, Zhen
    Wang, Jun
    ADVANCED DRUG DELIVERY REVIEWS, 2021, 168 : 3 - 29
  • [49] Advances in Industrial Biotechnology Using CRISPR-Cas Systems
    Donohoue, Paul D.
    Barrangou, Rodolphe
    May, Andrew P.
    TRENDS IN BIOTECHNOLOGY, 2018, 36 (02) : 134 - 146
  • [50] Occurrence and Diversity of CRISPR-Cas Systems in the Genus Bifidobacterium
    Briner, Alexandra E.
    Lugli, Gabriele Andrea
    Milani, Christian
    Duranti, Sabrina
    Turroni, Francesca
    Gueimonde, Miguel
    Margolles, Abelardo
    van Sinderen, Douwe
    Ventura, Marco
    Barrangou, Rodolphe
    PLOS ONE, 2015, 10 (07):